292.4p -7.4 -2.5%
Last Trade - 4:35pm
| Market Cap | £2.21bn |
| Enterprise Value | £4.71bn |
| Revenue | £2.98bn |
| Position in Universe | 282nd / 1804 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1,977 | 2,107 | 2,749 | 2,876 | 2,932 | 3,083 | 2,950 | 3,110 | +9.3% | ||
| -6.2 | -25.1 | +5.4 | +74.3 | -56.6 | +95.3 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Mediclinic International plc (Mediclinic) is an international private healthcare services provider. Mediclinic is focused on providing acute-care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic’s operational divisions includes Hirslanden Switzerland, Mediclinic Southern Africa and Mediclinic Middle East. Mediclinic comprises of 77 hospitals, five sub-acute hospitals, 14 day case clinics and 22 outpatient clinics. Hirslanden Switzerland operates 17 hospitals, two day case clinics and three outpatient clinics in Switzerland with over 1900 inpatient beds. Mediclinic Southern Africa operates 53 hospitals, five sub-acute hospitals and 10 day case clinics across South Africa and three hospitals in Namibia with over 8500 inpatient beds. Mediclinic Middle East operates seven hospitals, two day case clinics and 19 outpatient clinics with over 900 inpatient beds in the United Arab Emirates.
| Last Annual | March 31st, 2020 |
| Last Interim | September 30th, 2020 |
| Incorporated | December 20, 2012 |
| Public Since | June 26, 2013 |
| No. of Shareholders: | n/a |
| No. of Employees: | 33,140 |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | FTSE All Share , FTSE All-share - Health Care Price Return Gbp End Of Day, FTSE All-share - Health Care Equipment & Services Price Return Gbp End Of Day, FTSEurofirst 300 Health Care Equipment & Services , FTSE 350 , FTSE 350 Lower Yield , FTSE 250 , FTSE 350 Health Care Equipment & Services , , |
| Exchange | London Stock Exchange (Full) |
| Shares in Issue | 737,243,810 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 6th Fl 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom |
| Web | https://www.mediclinic.com/ |
| Phone | +44 20 79549600 |
| Contact | James Arnold (Head of Investor Relations) |
| Auditors | PricewaterhouseCoopers LLP |
As of 4:35pm, shares in Mediclinic International are trading at 292.4p, giving the company a market capitalisation of £2.21bn. This share price information is delayed by 15 minutes.
Shares in Mediclinic International are currently trading at 292.4p and the price has moved by -26.03% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Mediclinic International price has moved by -19.17% over the past year.
Of the analysts with advisory recommendations for Mediclinic International, there are there are currently 2 "buy" , 6 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Mediclinic International is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Mediclinic International is scheduled to issue upcoming financial results on the following dates:
Mediclinic International does not currently pay a dividend.
Mediclinic International does not currently pay a dividend.
Mediclinic International does not currently pay a dividend.
To buy shares in Mediclinic International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Mediclinic International are currently trading at 292.4p, giving the company a market capitalisation of £2.21bn.
Here are the trading details for Mediclinic International:
Based on an overall assessment of its quality, value and momentum, Mediclinic International is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Mediclinic International are currently priced at 292.4p. At that level they are trading at 11.5% discount to the analyst consensus target price of 330.40.
Analysts covering Mediclinic International currently have a consensus Earnings Per Share (EPS) forecast of 0.11717 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mediclinic International. Over the past six months, the relative strength of its shares against the market has been -6.17%. At the current price of 292.4p, shares in Mediclinic International are trading at 8.53% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Mediclinic International PE ratio based on its reported earnings over the past 12 months is 20.85. The shares are currently trading at 292.4p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Mediclinic International's management team is headed by:
Here are the top five shareholders of Mediclinic International based on the size of their shareholding:
